SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-024185
Filing Date
2020-05-11
Accepted
2020-05-11 16:11:42
Documents
54
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q reta-10q_20200331.htm   iXBRL 10-Q 1415965
2 EX-31.1 reta-ex311_13.htm EX-31.1 20536
3 EX-31.2 reta-ex312_8.htm EX-31.2 20600
4 EX-32.1 reta-ex321_9.htm EX-32.1 10182
5 EX-32.2 reta-ex322_6.htm EX-32.2 10162
6 GRAPHIC gjmt5ed01ema000001.jpg GRAPHIC 35447
  Complete submission text file 0001564590-20-024185.txt   4587815

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA reta-20200331.xsd EX-101.SCH 34938
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE reta-20200331_cal.xml EX-101.CAL 35657
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE reta-20200331_def.xml EX-101.DEF 140821
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE reta-20200331_lab.xml EX-101.LAB 293698
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reta-20200331_pre.xml EX-101.PRE 222920
40 EXTRACTED XBRL INSTANCE DOCUMENT reta-10q_20200331_htm.xml XML 586832
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37785 | Film No.: 20864888
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences